Shahidi F, Vafaei-Nezhad S, Saeidi M, et al
People are injecting counterfeit metabolic agents with no verification of contents
Xenical is contraindicated in chronic malabsorption syndrome and cholestasis
However, findings from other studies suggest that it may offer additional benefits, potentially warranting further research
Five articles were funded by pharmaceutical sponsors, who were also involved in the data analysis, so they were considered to have an unclear risk of bias for other bias
The replacement of Alanine 2 and 13 with Aib did not significantly change the binding affinity, but did result in a decline in potency as a substrate for DPP4